ENGERT, Andreas, Heinz HAVERKAMP, Carsten KOBE, Jana MARKOVA, Christoph RENNER, Antony HO, Josee ZIJLSTRA,
Zdeněk KRÁL, Michael FUCHS, Michael HALLEK, Lothar KANZ, Hartmut DOEHNER, Bernd DOERKEN, Nicole ENGEL, Max TOPP, Susanne KLUTMANN, Holger AMTHAUER, Andreas BOCKISCH, Regine KLUGE, Clemens KRATOCHWIL, Otmar SCHOBER, Richard GREIL, Reinhard ANDREESEN, Michael KNEBA, Michael PFREUNDSCHUH, Harald STEIN, Hans Theodor EICH, Rolf-Peter MUELLER, Markus DIETLEIN, Peter BORCHMANN a Volker DIEHL. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
Lancet. NEW YORK: ELSEVIER SCIENCE INC, 2012, roč. 379, č. 9828, s. 1791-1799. ISSN 0140-6736. Dostupné z: https://dx.doi.org/10.1016/S0140-6736(11)61940-5.